Presentation is loading. Please wait.

Presentation is loading. Please wait.

Sample-wise outlier kinases in ERBB2-positive breast cancer cell lines

Published byจตุพล บราวน์ Modified over 5 years ago

Similar presentations

Presentation on theme: "Sample-wise outlier kinases in ERBB2-positive breast cancer cell lines"— Presentation transcript:

1 Sample-wise outlier kinases in ERBB2-positive breast cancer cell lines.
Sample-wise outlier kinases in ERBB2-positive breast cancer cell lines. Left, the scatter plots display kinome expression profiles of individual breast cancer cell lines. Kinases with (red/pink) and without (green) outlier expression that were targeted for knockdown are shown in color. Labels in black denote additional kinases with outlier expression. Right, growth curves show the effect of targeting outlier (ERBB2) versus nonoutlier (RPS6KB1) kinases in ZR cells and the effects of trastuzumab and/or knockdown of the outlier FGFR4 in CAMA-1, MDA-MB-361, and MDA-MB-453 cells. Values represent mean ± SD. **, P < 0.01; ****, P < Vishal Kothari et al. Cancer Discovery 2013;3: ©2013 by American Association for Cancer Research

Download ppt "Sample-wise outlier kinases in ERBB2-positive breast cancer cell lines"

Similar presentations

Homozygous deletions within chromosome 9q23.

Homozygous deletions within chromosome 9q23.
Supplemental Material

Supplemental Material
Inhibition of FGFR fusion kinase activity repressed tumor growth in a mouse xenograft model. Inhibition of FGFR fusion kinase activity repressed tumor.

Inhibition of FGFR fusion kinase activity repressed tumor growth in a mouse xenograft model. Inhibition of FGFR fusion kinase activity repressed tumor.
سرطان الثدي Breast Cancer

سرطان الثدي Breast Cancer
CDK4 is required for the hormone-independent growth of ER+ breast cancer cells. CDK4 is required for the hormone-independent growth of ER+ breast cancer.

CDK4 is required for the hormone-independent growth of ER+ breast cancer cells. CDK4 is required for the hormone-independent growth of ER+ breast cancer.
A. D. B. C. - ΔNP63α - β-Actin IMEC - SUM MDA-MB IMEC

A. D. B. C. - ΔNP63α - β-Actin IMEC - SUM MDA-MB IMEC
PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation. PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation.

PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation. PI3K isoform–selective inhibitors and PTEN induction decrease ERK phosphorylation.
H3K4me3 pattern association with functionally relevant genes and changes over time. H3K4me3 pattern association with functionally relevant genes and changes.

H3K4me3 pattern association with functionally relevant genes and changes over time. H3K4me3 pattern association with functionally relevant genes and changes.
Genomic alterations in breast cancer cell line MDA-MB-231.

Genomic alterations in breast cancer cell line MDA-MB-231.
Copy-number alterations in an archival breast cancer sample.

Copy-number alterations in an archival breast cancer sample.
ECM 29 and Kaplan–Meier survival curves for additional datasets

ECM 29 and Kaplan–Meier survival curves for additional datasets
(A-B) Expression of dominant negative p73. (C) Knockdown of p73

(A-B) Expression of dominant negative p73. (C) Knockdown of p73
Chromosome 8 cDNA microarray gene expression profile of the amplified regions of 8p11–12 in SUM-44, -52, and -225 cells versus MCF10A HME control cells.

Chromosome 8 cDNA microarray gene expression profile of the amplified regions of 8p11–12 in SUM-44, -52, and -225 cells versus MCF10A HME control cells.
Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.

Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.
A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.

A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.

Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
USP2a regulates MYC expression through the MDM2–p53 axis.

USP2a regulates MYC expression through the MDM2–p53 axis.
CREB1 promotes the induction of endogenous ERα target genes.

CREB1 promotes the induction of endogenous ERα target genes.
A, IC50 dose–response curves of SYD985, T-DM1, and ADC isotype control in all USC cell lines tested in vitro (i.e., HER2 3+ cell lines, P =

A, IC50 dose–response curves of SYD985, T-DM1, and ADC isotype control in all USC cell lines tested in vitro (i.e., HER2 3+ cell lines, P =
SW fraction induces S phase arrest and apoptosis.

SW fraction induces S phase arrest and apoptosis.

Similar presentations

Ads by Google